Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-07-03
1998-11-17
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514143, 530324, 530330, 530352, 436 86, 436103, A61K 3800, A61K 3804, A01N 5710, C07K 500
Patent
active
058376747
ABSTRACT:
Phosphopeptides which significantly reduce bone loss or weakening are provided by the invention. Also provided is a method for treating or preventing any condition associated with bone loss or weakening by administering the phosphopeptides by oral or injectable means.
REFERENCES:
patent: 5015628 (1991-05-01), Reynolds
Boskey, A.L. et al., "Concentration-Dependent Effects of Dentin Phosphophoryn in the Regulation of in Vitro Hydroxyapatite Formation and Growth." Bone and Mineral (1990) 11:55-65.
Chappard, D., et al.,"Effects of Tiludonate on Bone Loss in Paraplegic Patients." J. Bone and Mineral Res. (1995) 10(1):112-118.
Doi, Y., et al., "Effects of Non-Collagenous Proteins on the formation of Apatite in Calcium .beta.-Glycerophosphate Solutions." Arch. Oral Biol., (1992) 37:15-21.
Gennari,C., et al. "Management of Osteoporosis and Paget's Disease: An Appraisal of the Risks and Benefits of Drug Treatment." Drug. Saf. (1994) 11(3):179-195.
Glimcher, E.G., et al., "Mechanism of Calcification: Role of Collagen Fibrils and Collagen-Phosphoprotein Complexes in Vitro and in Vivo." Ant Rec. (1989) 224:139-153.
Linde, A., et al., "Mineral Induction by Immobilized Proteins." Calcif. Tissue Int. (1989) 44:286-295.
Lufkin, E.G., et al., "Pamidronate: An Unrecognized Problem in Gastrointestinal Tolerability." Osteoporos Int. (1994) 4(6): 320-322.
Lussi, A., et al., "Induction and Inhibition of Hydroxyapatite Formation by Rat Dentine Phosphoprotein." Arch Oral Biol. (1988) 33:685-691.
Nawrot, C.F., et al., "Dental Phosphoprotein-Induced Formation of Hydroxyapatite during in Vitro Synthesis of Amorphous Calcium Phosphate." Biochemistry (1976) 51:3445-9.
van den Bos, T. et al., "Effect of Bound Phosphoproteins and Other Organic Phosphoproteins and Other Organic Phosphates on Alkaline Phosphatase-Induced Mineralization of Collagenous Matrices in Virtro." Bone and Mineral (1993) 23:81-93.
Kumagai Yoshinari
Otaka Akira
Achutamurthy Ponnathapura
Big Bear Bio, Inc.
Bozicevic Karl
Ponnaluri Padmashri
LandOfFree
Phosphopeptides and methods of treating bone diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphopeptides and methods of treating bone diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphopeptides and methods of treating bone diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-884459